Nortriptyline and debrisoquine hydroxylations in Ghanaian and Swedish subjects
- 1 September 1984
- journal article
- research article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 36 (3) , 374-378
- https://doi.org/10.1038/clpt.1984.190
Abstract
Ghanaian (11) and 12 Swedish subjects phenotyped by a debisoquine (D) hydroxylation test were given a single oral dose of nortriptyline (NT). Similar percentage of the given NT dose was excreted as 10-hydroxy-NT (10-OH-NT) by Ghanaians (43.1%) and Swedes (49.2%). A close correlation existed between plasma clearance of NT by 10-hydroxylation and the D metabolic ratio (D/4-OH-D in urine) in the Ghanaians (rs = -0.95; P < 0.01) and Swedes (rs = -0.84; P < 0.01). The E-isomer of 10-OH-NT is the major isomer in both Ghanaians (76%-92% of total 10-OH-NT) and Swedes (78%-95%). The E-10-hydroxylation of NT and the 4-hydroxylation of D evidently are similarly co-regulated in Ghanaians and Swedes.This publication has 7 references indexed in Scilit:
- Comparative pharmacogenetics of sparteine and debrisoquineClinical Pharmacology & Therapeutics, 1983
- Genetic polymorphism of phenformin 4-hydroxylationClinical Pharmacology & Therapeutics, 1982
- E- and Z-10-hydroxylation of nortriptyline: Relationship to polymorphic debrisoquine hydroxylationClinical Pharmacology & Therapeutics, 1981
- Nortriptyline and antipyrine clearance in relation to debrisoquine hydroxylation in manLife Sciences, 1980
- Debrisoquin hydroxylation polymorphism among Ghanaians and CaucasiansClinical Pharmacology & Therapeutics, 1979
- Defective N-oxidation of sparteine in man: A new pharmacogenetic defectEuropean Journal of Clinical Pharmacology, 1979
- POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MANThe Lancet, 1977